Only four of 17 analysts rate Macy’s stock as a Buy, and none has a Strong Buy rating. Another eight rate the shares at Hold and five have Sell or Strong Sell ratings. At a share price of around $25.40, the upside potential based on a median price target of $31.40 is 23.6%. Based on a high price target of $50, the potential upside on the shares is almost 97%.

Analysts are forecasting fourth-quarter fiscal 2022 revenue of $8.45 billion, which would be 55.3% higher sequentially and up about 24.6% year over year. Adjusted EPS are tabbed at $1.99, up 62% sequentially and 149% year over year. For the fiscal year ending in January, analysts are currently looking for EPS of $4.88, compared to last year’s loss of $2.21 per share, on sales of $24.23 billion, up nearly 40%.

Macy’s stock trades at 5.3 times expected 2022 EPS, 6.4 times estimated 2023 earnings of $4.02 and 6.6 times estimated 2024 earnings of $3.94 per share. The stock’s 52-week range is $13.73 to $37.95. The company pays an annual dividend of $0.15 (yield of 2.32%). Total shareholder return for the past year is 83.2%.

Medtronic

Medical device maker Medtronic PLC (NYSE: MDT) has posted a share price decline of around 12% over the past 12 months. Between early September and late December, the stock price dropped by 26%. Prior-quarter results were dampened by lower demand for elective surgeries, and investors will be looking at that metric again for the company’s fiscal third quarter. Medtronic reports results before markets open on Tuesday.

Analysts are bullish on the stock, with 19 of 27 ratings at Buy or Strong Buy, and the other eight ratings are all Hold. At a share price of around $101.40, the upside potential based on a median price target of $128 is 26.2%. At the high price target of $153, the upside potential is nearly 51%.

Analysts expect the company to report third-quarter revenue of $7.91 billion, up less than 1% sequentially and up 1.7% year over year. Adjusted EPS are forecast at $1.37, up 3.6% sequentially and about 6.0% year over year. Current estimates for fiscal 2022 call for EPS of $5.68, up 27.9%, on sales of $32.26 billion, up 7.1%.

Macy’s stock trades at 17.9 times expected 2022 EPS, 16.5 times estimated 2023 earnings of $6.14 and 15.3 times estimated 2024 earnings of $6.66 per share. The stock’s 52-week range is $98.38 to $135.89. The company pays an annual dividend of $2.42 (yield of 2.48%). Total shareholder return for the past year was negative 10.2%.